How many studies have been conducted on Ergoloid Mesylates?

BiohacksAI has indexed 32 PubMed studies on Ergoloid Mesylates, including 3 randomized controlled trials (RCTs). 75% of studies involve human subjects.

What are the main research areas for Ergoloid Mesylates?

The primary research domains for Ergoloid Mesylates are 🧠 Neuroprotection, 🧠 Cognitive, ❤️ Cardiovascular. This is based on analysis of 32 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Ergoloid Mesylates

A mixture of the mesylates (methane sulfonates) of DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and the alpha- and beta-isomers of DIHYDROERGOCRYPTINE. The substance produces a generalized peripheral vasodilation and a fall in arterial pressure and has been used to treat symptoms of mild to moderate impairment of mental function in the elderly.

32+ PubMed studies analyzed · 3 RCTs · Evidence Score: 50

Research Domains

Ergoloid Mesylates has been studied across 12 research domains including 🧠 Neuroprotection, 🧠 Cognitive, ❤️ Cardiovascular, 🌤️ Mood & Depression, ⏳ Longevity & Aging. The primary research focus is 🧠 Neuroprotection with 59% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ergoloid Mesylates is generated deterministically from 32 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.